SightfileU.S. market data from official filings
Companies › DRTS
ALPHA TAU MEDICAL LTD (DRTS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001871321 · EDGAR filings · Updated 2026-07-21
ALPHA TAU MEDICAL LTD (DRTS) has reported institutional ownership of 4.6%, with 53 institutional managers holding positions valued at $29.1M per the latest 13F reporting period.
Institutional ownership
4.6%
Institutional managers
53
Reported 13F value
$29.1M
Latest updates
- 2026-07-21 — Foreign issuer report (6-K) filed
- 2026-07-15 — Foreign issuer report (6-K) filed
- 2026-07-07 — Insider transaction reported (Form 4)
- 2026-07-06 — Notice of proposed sale filed (Form 144)
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ALPHA TAU MEDICAL LTD has 53 institutional holders and institutional ownership of 4.6%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.
Related companies
AGENUS INC (AGEN) · LENSAR INC (LNSR) · CAPSOVISION INC (CV) · EXAGEN INC (XGN) · Elicio Therapeutics Inc (ELTX) · CANOPY GROWTH CORPORATION (CGC)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.